We specialize in NGS (next generation sequencing) and medical diagnostics. We are the first in Poland and one of the first ten in the world laboratories using nanopore sequencing technology in many areas of science, business and medicine.
We offer NGS sequencing (next generation sequencing) in nanopore technology developed by Oxford Nanopore Technologies. This unique technology allows you to analyze nucleic acids without having to introduce an amplification step during library creation.
After a detailed medical interview, diagnostic molecular tests are the fastest and best tool in diagnosing most diseases and assessing the patient's health condition.
19 July 2021
We are happy to announce the launch of the first partner swab collecting point, located at the MTP Poznań Expo, in pavilion 7 (at gate 2) – entrance from Śniadeckich Street. The point is open from 8:00 to 21:00. Prior registration is required: tel 605 50 40 20. Payment by card on the spot. The […]
25 June 2021
25.06.2021 World Microbiome Day
June 27 is #worldmicrobiomeday – World Microbiome Day. We celebrate this day by issuing gut microbiota study reports for the last participants of our research project. Our database is updated and ready for further analysis. But because we also care about the vaginal microbiota, we have launched a special price for a test that describes […]
18 June 2021
We are sorry that the news service was unavailable for technical reasons. Fortunately, the troubles are behind us and we are back with some news from the company: research and development team conducts activities aimed at realization of the contracts with Sanitary-Epidemiological Stations; yesterday’s conference at WSSE Olsztyn, in which the successful project of nanopore […]
14 May 2021
14.05.2021 Periodic Report for I Quarter
Today is the quarterly report publication date. Therefore, we invite you to the Q&A session about genXone. Questions about activities, ongoing project and research please send to: firstname.lastname@example.org entitled “Q&A genXone”. We are waiting for your questions until Tuesday, we will publish the answers in the News section as soon as possible.
10 May 2021
The nanopore sequencing technology used by our company is gaining the importance. Our Research and Development team has carried out research in many areas, here are some notable examples: We submitted almost 2300 records to the GISAID database in the coronavirus genome sequencing project, which is about 24% of all Polish entries in the database. […]
30 April 2021
April in genXone
We are pleased to announce that the tasks planned as a part of the projects proceed without any obstacles and we consistently achieve the assumed goals: Nanobiome project – results for the first part of the volunteers were published. The remaining reports will be released in the coming weeks. SARS-CoV-2 genome sequencing project – we […]
23 April 2021
inwestorzy.tv interview & new swab collection point
Yesterday (thursday, April 22, 2021), an interview with the CEO Michał Kaszuba was published on the Inwestorzy.tv channel. It was about the current state of the projects we are working on. Yesterday we also launched another testing point. It is located on the premises of the City Hospital in Oborniki Wielkopolskie.
16 April 2021
Spring in genXone!
Notable things that happened in the first months of spring: We received the WSE (pl. GPW) award for the highest value of an issuer debuting on NewConnect. Thank you! Within 2 weeks, the Research and Development Team completed 30% of the year-long research project carried out with the Małopolska Center of Biotechnology of the Jagiellonian […]